Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Sep;12(9):1087-1088.
doi: 10.1002/alr.23039. Epub 2022 Jun 23.

Can we make biologic therapy more affordable?

Affiliations
Editorial

Can we make biologic therapy more affordable?

Ameen Biadsee et al. Int Forum Allergy Rhinol. 2022 Sep.
No abstract available

Keywords: CRSwNP; anti-IL-4; aspirin exacerbated respiratory disease, biologic therapy; chronic rhinosinusitis with nasal polyposis; dupilumab; monoclonal antibody.

PubMed Disclaimer

References

REFERENCES

    1. Smith KA, Orlandi RR, Rudmik L. Cost of adult chronic rhinosinusitis: a systematic review. Laryngoscope. 2015;125(7):1547-1556. https://doi.org/10.1002/lary.25180
    1. Yong M, Wu YQ, Howlett J, Ballreich J, Walgama E, Thamboo A. Cost-effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease. Int Forum Allergy Rhinol. 2021;11(12):1626-1636. https://doi.org/10.1002/alr.22865
    1. Rathi VK, Scangas GA, Metson RB, Xiao R, Nshuti L, Dusetzina SB. Out-of-pocket costs of biologic treatments for chronic rhinosinusitis with nasal polyposis in the Medicare population [published online ahead of print January 14, 2022]. Int Forum Allergy Rhinol. https://doi.org/10.1002/alr.22976
    1. Thamboo A, Kilty S, Witterick I, et al. Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2021;50(1):15. https://doi.org/10.1186/s40463-021-00493-2
    1. Roland LT, Smith TL, Schlosser RJ, et al. Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: discussion from a National Institutes of Health-sponsored workshop. Int Forum Allergy Rhinol. 2020;10(9):1037-1042. https://doi.org/10.1002/alr.22633

Publication types

LinkOut - more resources